About this Event
In collaboration with Lehane Consulting
Join us for this exciting event bringing together experts, innovators and practitioners committed to improving diagnostic pathways and technologies for women.
Programme Overview
9:30: Welcome, tea & coffee
10:00 - 10:20 Lucy Lehane, Lehane Consulting
"Are we there yet? The journey so far for diagnostic testing in Women's health"
10:20 - 10:40 Aileen McGettrick, Prolight Diagnostics
""The role and potential benefits of high sensitivity point of care diagnostics.""
10:40 - 11:10 Paul Davis, Austin Davis
“Pee, Plants and Blue Particles: a brief review of the curious history of pregnancy testing”
11:00 - 11:20 Tea & Coffee networking break
11:20 - 12:20 Breakout Sessions:
Inclusive Innovation
Unfulfilled Ambitions: Challenges in the development and adoption pathway
Led by Lavinia Pamparau, Health Innovation Network London
Point of need: Is access to diagnostics for women aligned with women’s lives?
Led by Lucy Lehane
12:30 to 13:30 Networking Lunch
13:20 - 13:50 MaryAnn Ferreux, Health Innovation KSS, NIHR, Kent & Medway NHS Partnership Trust
"From Bias to Better Outcomes: Using a Health Equity Lens to Shape Women’s Health Innovation"
13:50 - 14:10 Shema Tariq, UCL
"This Might Be a Bit Uncomfortable: Rethinking Women’s Healthcare Through the Speculum".
14:10 - 14:40 Panel Session
Including:
Ruth Bradbury, Health Innovation Network London
Shema Tariq, UCL
Keiko Yata, TTP
Chair: Lucy Lehane, Lehane Consulting
With more to be announced
15:00 - 15:50 Innovation Showcase
Short presentations from innovative start-ups including:
Elena Provaggi, Daye Ltd,
Jasmine Tagesson Hormona
with more still to be announced.
15:50 - 16:00 Closing remarks
When you sign up to this event we are offering a choice between three breakout sessions to select from:
1. Inclusive innovation
Women across the world are being underserved by healthcare services that in many ways do not reflect the specific needs of half the population. Diagnostic tests and procedures are subject to the same criticism – being mostly designed and validated with males in mind. The consequences of inaccurate diagnoses on women’s health are well documented, and this is an urgent challenge that must be addressed. How can diagnostic developers improve the design, function and appropriateness of products for women from diverse populations? How can supply chains and health services improve access and affordability for a population growing in both size and diversity? How can the diagnostics industry deliver to women the diagnostic products they need and want?
2. Unfulfilled ambitions: Challenges in the development and adoption pathway.
All diagnostic products face challenges during development and market launch, but do women’s healthcare diagnostics face additional barriers? Are we yet looking sufficiently at the specifics of biomarkers in the context of women’s health? Are designers truly considering usability for female customers? What are the drivers influencing market positioning and uptake for professional-use only and self-test products?
3. Point of need: Is access to diagnostics for women aligned with women’s lives?
Is the establishment of community diagnostic hubs beneficial for women? Could better provision be made for access to diagnostics across cultures and different age demographics? The rise of self-test products aimed at women has surged in recent years, but are women getting what they really need - or what they are told they need? And is the integration of data from home testing into the patient record helping to maintain the patient journey?
Event Venue & Nearby Stays
30 Guilford St, 30 Guilford Street, London, United Kingdom
GBP 0.00
